Fundraising FoxExubrion
1 known investors
Find your way into Exubrion
Sign up to see every warm intro you have to Exubrion
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Exubrion team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Exubrion Therapeutics develops veterinary therapies using conversion electron therapy from Tin-117m to treat pain and inflammation in companion animals. Its initial product, Synovetin OA, is a minimally invasive intra-articular injection for canine elbow osteoarthritis, marketed to veterinarians and pet owners.
Investors · 1
Frequently asked questions
- What does Exubrion do?
- Exubrion Therapeutics develops veterinary therapies using conversion electron therapy from Tin-117m to treat pain and inflammation in companion animals. Its initial product, Synovetin OA, is a minimally invasive intra-articular injection for canine elbow osteoarthritis, marketed to veterinarians and pet owners.
- Who are Exubrion's investors?
- Exubrion's investors include Mountain Group Capital.